The Stillbirth Summit continued to gain momentum early in the morning with Uma Reddy, MD, MPH, Medical Officer, Pregnancy & Perinatology Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Bethesda, MD presenting Thrombosis and Adverse Pregnancy Outcomes. Dr. Reddy is a wealth of knowledge and at times I am sure the researchers understood a lot more than I certainly did!!!
Venous thromboembolism and adverse pregnancy outcomes are potential complications of pregnancy. Numerous studies have evaluated both the risk factors for and the prevention and management of these outcomes in pregnant patients. Reddy stated the American College of Obstetricians and Gynecologists (ACOG) just came out with their new recommendations for Preventing Thromboembolism in pregnant women.
Please read and digest this information which breaks down the new guidelines. She also informed us aspirin and lovenox (a blood thinner) are indicated to be given for the duration of a pregnancy for women with prior thromboembolic disease ~ and ~ may be given safely.
Women who have had any thromboembolic disease should have a full coagulation profile performed. Prescribing anticoagulants to pregnant women can be difficult and stressful. Maternal and fetal concerns must be considered at all times, with a careful assessment of the risks and benefits of anticoagulant therapy in each patient. Further research should help to clarify who should receive thromboprophylaxis, how to prevent adverse pregnancy outcomes in women with various thrombophilias, and how best to treat pregnant women who have a prosthetic heart valve.
No comments:
Post a Comment